Future studies are necessary to clarify the mechanisms that can override the impact of the cell cycle inhibitory effects of SKP2 deletion in T-ALL blasts and to determine the contribution of non-cell autonomous factors, such as BM microenvironment and the immune response. Here, SKP2 is linked to acute lymphoblastic leukemia.